SBC Medical Group Holdings Incorporated (SBC) Debt Components
- 2026-06-30: Notes Payable, CurrentUSD (m); Debt, CurrentUSD $203.51K; Unsecured DebtJPY (m); Unsecured DebtUSD (m).
- 2026-03-31: Notes Payable, CurrentUSD (m); Debt, CurrentUSD $219.60K; Unsecured DebtJPY (m); Unsecured DebtUSD (m).
- 2025-12-31: Notes Payable, CurrentUSD (m); Debt, CurrentUSD $228.21K; Unsecured DebtJPY 50.00M; Unsecured DebtUSD (m).
- 2025-12-31: Notes Payable, CurrentUSD $0.00; Debt, CurrentUSD (m); Unsecured DebtJPY (m); Unsecured DebtUSD $334.17K.
SBC Medical Group Holdings Incorporated Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Notes Payable, Current USD | Debt, Current USD | Unsecured Debt JPY | Unsecured Debt USD | Convertible Notes Payable USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Line of Credit Facility, Fair Value of Amount Outstanding USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Short-term Debt USD | Notes Payable, Related Parties, Current USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $203.51K | (m) | (m) | (m) | $37.75M | $8.26M | $10.40M | $7.19M | $6.67M | $5.24M | $0.00 | (m) | $1.19M | $1.88M | (m) | (m) |
| 2026-03-31 | (m) | $219.60K | (m) | (m) | (m) | $40.44M | $7.23M | $13.74M | $7.33M | $6.80M | $5.35M | $0.00 | (m) | $1.21M | $1.92M | (m) | (m) |
| 2025-12-31 | (m) | $228.21K | 50.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.21M | $1.92M | (m) | (m) |
| 2025-12-31 | $0.00 | (m) | (m) | $334.17K | (m) | $42.83M | $9.10M | $13.95M | $7.44M | $6.91M | $5.44M | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $1.64M | $250.49K | (m) | (m) | (m) | $21.12M | $3.04M | $9.79M | $2.97M | $2.97M | (m) | $1.59M | $757.63K | (m) | (m) | (m) | (m) |
| 2025-06-30 | $3.27M | $266.57K | (m) | (m) | (m) | $7.10M | $69.42K | $7.00M | (m) | (m) | (m) | (m) | $31.82K | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.42M | $266.01K | (m) | (m) | (m) | $6.86M | $66.95K | $6.75M | (m) | (m) | (m) | (m) | $47.42K | (m) | (m) | (m) | (m) |
| 2024-12-31 | $26.25K | $262.10K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | $0.00 | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | $6.60M | $96.82K | $66.58K | $6.44M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | $2.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $10.20M | (m) | (m) | (m) | (m) | $823.15K | $141.93K | $147.19K | $140.90K | $77.12K | (m) | (m) | $31.55K | (m) | (m) | (m) | (m) |
| 2024-09-17 | (m) | (m) | (m) | (m) | $2.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $2.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.70M | (m) |
| 2023-12-31 | $3.37M | $329.15K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.00M | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $300.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |